McDavid Stilwell

CHRS

McDavid Stilwell serves as Chief Financial Officer at Coherus Oncology, Inc. (CHRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$49.7K

Total Sells

1 trades

$58.9K

Net Position

Net Seller

$9.3K

Companies Traded

CHRS

Active Period

Jun 2021 – Oct 2021

2 total trades

Most Recent

Sell CHRS

Oct 19, 2021 · $58.9K

McDavid Stilwell's Insider Trading at Coherus Oncology, Inc. (CHRS)

Buys

1 · $49.7K

Sells

1 · $58.9K

Total Shares Bought

3,700

Total Shares Sold

3,507

CHRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 19, 2021	Sell	3,507	$16.80	$58.9K	31,611
Jun 10, 2021	Buy	3,700	$13.42	$49.7K	35,118

Explore More Insider Trading Data

CHRS Insider Trading Activity

View all insider trades at Coherus Oncology, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity